Tudor Investment Corp’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-43,865
| Closed | -$95.6K | – | 1587 |
|
|
2024
Q1 | $95.6K | Sell |
43,865
-865
| -2% | -$1.89K | ﹤0.01% | 1367 |
|
|
2023
Q4 | $69.3K | Hold |
44,730
| – | – | ﹤0.01% | 1385 |
|
|
2023
Q3 | $57.7K | Hold |
44,730
| – | – | ﹤0.01% | 1406 |
|
|
2023
Q2 | $76.9K | Hold |
44,730
| – | – | ﹤0.01% | 1444 |
|
|
2023
Q1 | $68K | Sell |
44,730
-118,267
| -73% | -$180K | ﹤0.01% | 1462 |
|
|
2022
Q4 | $261K | Hold |
162,997
| – | – | 0.01% | 1297 |
|
|
2022
Q3 | $236K | Hold |
162,997
| – | – | 0.01% | 1365 |
|
|
2022
Q2 | $298K | Hold |
162,997
| – | – | 0.01% | 1242 |
|
|
2022
Q1 | $435K | Buy |
+162,997
| New | +$435K | 0.01% | 1148 |
|
|
2021
Q1 | – | Sell |
-51,873
| Closed | -$340K | – | 1573 |
|
|
2020
Q4 | $340K | Sell |
51,873
-47,068
| -48% | -$309K | 0.01% | 1069 |
|
|
2020
Q3 | $658K | Buy |
98,941
+74,370
| +303% | +$495K | 0.03% | 713 |
|
|
2020
Q2 | $205K | Sell |
24,571
-18,720
| -43% | -$156K | 0.01% | 1012 |
|
|
2020
Q1 | $332K | Sell |
43,291
-35,488
| -45% | -$272K | 0.03% | 652 |
|
|
2019
Q4 | $655K | Buy |
+78,779
| New | +$655K | 0.03% | 634 |
|